Zobrazeno 1 - 10
of 331
pro vyhledávání: '"M, Algara"'
Autor:
M. Algara, M. Arenas, J. Marin, I. Vallverdu, P. Fernandez-Letón, J. Villar, G. Fabrer, C. Rubio, A. Montero
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 24, Iss , Pp 29-33 (2020)
Background: COVID-19 is a highly contagious viral infection with high morbidity that is draining health resources. The biggest complication is pneumonia, which has a serious inflammatory component, with no standardized treatment. Low-dose radiation t
Externí odkaz:
https://doaj.org/article/cec62de3850a477a927702b4b631389b
Autor:
M. Arenas, B. Piqué, L. Torres-Royo, J. C. Acosta, E. Rodríguez-Tomàs, G. De Febrer, C. Vasco, P. Araguas, J. A. Gómez, B. Malave, M. Árquez, M. Algara, A. Montero, M. Montero, J. M. Simó, X. Gabaldó, D. Parada, F. Riu, S. Sabater, J. Camps, J. Joven
Publikováno v:
Strahlentherapie und Onkologie.
Autor:
Albert Martínez, J. Dengra, P. Pérez, I. Membrive, Y Huang, Palmira Foro, M. Zhao, Nuria Rodríguez, F. Liu, M. Algara, A. Reig, Julián Sanz, X Li, X. Duran, M. Conde
Publikováno v:
Clinical & Translational Oncology
Purpose Radiation-induced toxicity (RIT) is usually assessed by inspection and palpation. Due to their subjective and unquantitative nature, objective methods are required. This study aimed to determine whether a quantitative tool is able to assess R
Autor:
J.C. Acosta Arteaga, L. Torres Royo, E. Rodríguez-Tomàs, G. De Febrer, C. Vasco, J.A. Gomez, P. Araguas, B. Malave, M. Arquez, M. Algara, A. Montero, M. Montero, J.M. Simo, X. Gavaldà, B. Pique, D. Parada, S. Sabater, J. Camps, J. Joven, M. Arenas
Publikováno v:
Radiotherapy and Oncology. 170:S1229-S1231
Autor:
M. Algara López, O. Pera Cegarra, F. Liu Cheng, P. Foro Arnalot, G. Deza, N. Rodriguez De Dios, J. Quera Jordana, X. Sanz Latiesas, E. Fernandez-Velilla Cepria, A. Reig Castillejo, I. Membrive Conejo, A. Martínez Moñino
Publikováno v:
Clinical and Translational Oncology. 24:578-585
Purpose Our center adopted high-dose-rate brachytherapy with surface applicators (plesiotherapy) in 2008, creating custom molds to treat irregular areas. This study describes the efficacy and safety outcomes after extensive follow-up in the patients.
Autor:
Angel Montero, D. Jové, O. Ripol, C. Solé, M. Algara, S. Vázquez, E. Garcia, L. Gutiérrez, Meritxell Arenas, Marta Bonet, M. Visus, M. Mira, J. L. Morales-Rull
Publikováno v:
Clinical & Translational Oncology
Background The use of low dose radiotherapy (LD-RT) for the treatment of COVID-19 pneumonia is supported by biological rationale for its immunomodulatory effect. Some institutions have started to treat these patients showing encouraging results. To s
Autor:
M. Algara, A. Eraso, C. Muñoz-Montplet, Yolande Lievens, Noémie Defourny, J. Corral, Jordi Giralt, J.M. Borras, Josep A. Espinàs, J. Solà
Publikováno v:
Radiotherapy and Oncology. 161:S30-S32
Autor:
Marta Jiménez, Nuria Rodríguez, Nuria Argudo, Rogelio Andrés-Luna, Ricardo Pardo, Rajiv V. Dave, María Angeles Montero-Fernández, Irene Osorio, Pilar Orihuela, M. Algara, Mar Vernet, Antoni Piñero, Raúl Córdoba, Sergio Salido, Pau Nicolau, Susan Pritchard, X. Sanz, Juan Bernar, Angel Montero, Natália Alves, Raquel Ciérvide
Publikováno v:
Revista de Senología y Patología Mamaria
We are facing a pandemic that is going to affect a significant part of the population. At the end of April in the world there are about 3,000,000 cases, with 205,000 deaths and 860,000 patients recovered. The response to this pandemic has in many cas
Autor:
P. Masó, M. Jiménez, S. Vidal-Sicart, R. Alcantara, N. Argudo, P. Nicolau, M. De Miguel, A. Martínez, Y. Aguilar, L. Rubio, R. Valhondo, N. Arenas, M. Pitarch, I. Vázquez, L. Comerma, J. Sanz, M. Algara, A. Noguera, M. Vernet-Tomas
Publikováno v:
European Journal of Cancer. 175:S16
Autor:
I, Membrive Conejo, O, Pera Cegarra, P, Foro Arnalot, A, Reig Castillejo, N, Rodríguez de Dios, X, Sanz Latiesas, G, Deza, J, Quera Jordana, E, Fernandez-Velilla Cepria, A, Martínez Moñino, F, Liu Cheng, M, Algara López
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 24(3)
Our center adopted high-dose-rate brachytherapy with surface applicators (plesiotherapy) in 2008, creating custom molds to treat irregular areas. This study describes the efficacy and safety outcomes after extensive follow-up in the patients.We plann